OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Early investment in formulation strategies will maximize the chance of success.
Advances in simulation and the development of digital twins.
Different methods give different answers when calculating limits for impurities.
Automatic visual inspection machines and AI highlight inspection deficits.
Despite their promise, alternative drug delivery approaches are complex and must be justified.
Traditional statistical process control rules can be relaxed or adjusted to allow charting and evaluation of real-life data.
Novavax COVID-19 Vaccine Receives EUA in Indonesia
November 29, 2021
The Comirnaty vaccine received a positive opinion from the EMA’s CHMP for children five to under 12 years of age.
Samsung Biologics will manufacture GreenLight BioSciences' COVID-19 vaccine candidate for clinical trials and commercial sales.
PathoQuest is the first French contract research organization (CRO) capable of offering GMP grade NGS-based testing services for quality control of biological drugs.
Donaldson Company's acquisition of Solaris Biotechnology is intended to expand their footprint in the life sciences market.
Flywheel's platform will aid Roche and Genentech in the aggregation and management of medical imaging data.
November 26, 2021
ACG plans to open a capsule manufacturing plant and R&D center in Aurangabad, India.
The study found that patients treated with BIMZELX (bimekizumab) achieved 50% or greater improvement in arthritis signs and symptoms relative to those treated with placebo.
Biogen received MHRA marketing authorization for VUMERITY (diroximel fumarate) for treatment of relapsing-remitting multiple sclerosis (RRMS).
Benchling raised $100 million to expand in Europe and further develop it's cloud-based R&D platform.
November 25, 2021
AstraZeneca has unveiled its new facility, The Discovery Centre, which will be used to support the company's focus on precision and specialized medicines, and to foster industry collaboration.